Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma
Exploration of Drug Science · 13.09.2024 · 567-582
DOI: 10.37349/eds.2024.00062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration of Drug Science, online erschienen am 13.09.2024. Verfasst von Sasikumar Jalajakumari Soumya und 7 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Kerala State Council for Science, Technology and Environment.
Abstract (Originalsprache)
Glioblastoma (GBM) remains a formidable challenge in neuro-oncology due to its aggressive nature and propensity for therapeutic resistance. Anti-vascular endothelial growth factor (VEGF) therapies, although promising, often encounter resistance that limits their clinical efficacy. A multi-target and multi-drug approach has emerged as compelling strategies to address this resistance to enhance the treatment outcomes. This review examines the complex environment of anti-VEGF resistant GBM and analyses a multi-target therapeutic approach using natural products.
Förderung
- Kerala State Council for Science, Technology and Environment
Zitieren
APA
Soumya, S. J., Arya, K. R., Abhinand, C. S., Sunitha, P., Athira, A. P., Nair, A. S., Oommen, O. V., & Sudhakaran, P. R. (2024). Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma. Exploration of Drug Science, 567-582. https://doi.org/10.37349/eds.2024.00062
Vancouver
Soumya SJ, Arya KR, Abhinand CS, Sunitha P, Athira AP, Nair AS, et al. Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma. Exploration of Drug Science. 2024:567-582. doi:10.37349/eds.2024.00062
BibTeX
@article{Soumya2024,
author = {Soumya, Sasikumar Jalajakumari and Arya, Kesavan Rathi and Abhinand, Chandran Sheela and Sunitha, Padmanabhan and Athira, Ajitha Prabhakaran and Nair, Achuthsankar Sukumaran and Oommen, Oommen V. and Sudhakaran, Perumana R.},
title = {Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma},
journal = {Exploration of Drug Science},
year = {2024},
pages = {567--582},
doi = {10.37349/eds.2024.00062}
}
EUVIMED